Position in NEO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$29,180
+$21,760 QoQ
Shares Held
2,000
+100.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#204
of 265 holders
Holding Since
Sep 2025
4 quarters on record
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $2,291,598 across 9 Diagnostics & Research names. NEO ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
1,042 | $548,550 | |
| 2 | LH |
Labcorp Holdings Inc.
|
1,500 | $420,000 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
824 | $413,120 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,500 | $289,830 | |
| 5 | DHR |
Danaher Corp /De/
|
1,514 | $288,386 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,080 | $228,906 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
50 | $63,875 | |
| 8 | NEO |
Neogenomics Inc
This page
|
2,000 | $29,180 |
All Filings in NEO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,180 | 2,000 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $7,420 | 1,000 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $11,760 | 1,000 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $7,720 | 1,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||